» Articles » PMID: 37623340

Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work

Abstract

Obesity is a growing public health epidemic worldwide and is implicated in slowing improved life expectancy and increasing cardiovascular (CV) risk; indeed, several obesity-related mechanisms drive structural, functional, humoral, and hemodynamic heart alterations. On the other hand, obesity may indirectly cause CV disease, mediated through different obesity-associated comorbidities. Diet and physical activity are key points in preventing CV disease and reducing CV risk; however, these strategies alone are not always sufficient, so other approaches, such as pharmacological treatments and bariatric surgery, must support them. Moreover, these strategies are associated with improved CV risk factors and effectively reduce the incidence of death and CV events such as myocardial infarction and stroke; consequently, an individualized care plan with a multidisciplinary approach is recommended. More precisely, this review explores several interventions (diet, physical activity, pharmacological and surgical treatments) to address CV risk in obese patients and emphasizes the importance of adherence to treatments.

Citing Articles

Vitamin D: A Bridge between Kidney and Heart.

Secondulfo C, Visco V, Virtuoso N, Fortunato M, Migliarino S, Rispoli A Life (Basel). 2024; 14(5).

PMID: 38792638 PMC: 11123235. DOI: 10.3390/life14050617.


Relevance of obesity-related organ damage and metabolic syndrome classification in cardiovascular and renal risk stratification in patients with essential hypertension.

Petramala L, Gigante A, Sarlo F, Servello A, Circosta F, Marino L Front Cardiovasc Med. 2024; 11:1369090.

PMID: 38606379 PMC: 11008466. DOI: 10.3389/fcvm.2024.1369090.

References
1.
Fitch A, Bays H . Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2023; 1:100004. PMC: 10661988. DOI: 10.1016/j.obpill.2021.100004. View

2.
Matsuo T, So R, Takahashi M . Estimating cardiorespiratory fitness from heart rates both during and after stepping exercise: a validated simple and safe procedure for step tests at worksites. Eur J Appl Physiol. 2020; 120(11):2445-2454. DOI: 10.1007/s00421-020-04457-8. View

3.
Strasser B, Schobersberger W . Evidence for resistance training as a treatment therapy in obesity. J Obes. 2010; 2011. PMC: 2931407. DOI: 10.1155/2011/482564. View

4.
Meeusen R, Duclos M, Foster C, Fry A, Gleeson M, Nieman D . Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. Med Sci Sports Exerc. 2012; 45(1):186-205. DOI: 10.1249/MSS.0b013e318279a10a. View

5.
Han K, Cao P, Wang Y, Xie F, Ma J, Yu M . A Review of Approaches for Predicting Drug-Drug Interactions Based on Machine Learning. Front Pharmacol. 2022; 12:814858. PMC: 8835726. DOI: 10.3389/fphar.2021.814858. View